FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Kalayajian Karen		 2. Date of Event Requiring Statement (MM/DD/YYYY)
4/13/2023 

 3. Issuer Name and Ticker or Trading Symbol

IntelGenx Technologies Corp. [IGXT]
(Last)        (First)        (Middle)

4896 RUE EDOUARD-BRUNETTE		 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
VP, Finance&Admin - Subsidiary /
(Street)

LAVAL, A8 H7T 0J4      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		2. Amount of Securities Beneficially Owned
(Instr. 4)		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, (p.v. 0.00001) 50000 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)		2. Date Exercisable and Expiration Date
(MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Options, right to buy (p.v. 0.00001) 9/15/2018 9/14/2026 Common Stock 100000 $0.73 D  
Options, right to buy (p.v. 0.00001) 12/27/2018 12/27/2026 Common Stock 40000 $0.76 D  
Options, right to buy (p.v. 0.00001) 11/24/2022 11/23/2030 Common Stock 75000 $0.27 D  
Options, right to buy (p.v. 0.00001) 12/10/2022 12/9/2031 Common Stock 50000 $0.44 D  
Options, right to buy (p.v. 0.00001) 6/10/2023 12/9/2031 Common Stock 25000 $0.44 D  
Options, right to buy (p.v. 0.00001) 12/10/2023 12/9/2031 Common Stock 25000 $0.44 D  
Options, right to buy (p.v. 0.00001) 1/29/2024 (1)1/28/2033 Common Stock 6250 $0.24 D  
Options, right to buy (p.v. 0.00001) 1/29/2025 (1)1/28/2033 Common Stock 6250 $0.24 D  
Options, right to buy (p.v. 0.00001) 1/29/2026 (1)1/28/2033 Common Stock 6250 $0.24 D  
Options, right to buy (p.v. 0.00001) 1/29/2027 (1)1/28/2033 Common Stock 6250 $0.24 D  
Options, right to buy (p.v. 0.00001) 10/4/2023 4/3/2033 Common Stock 12500 $0.19 D  
Options, right to buy (p.v. 0.00001) 4/4/2024 4/3/2033 Common Stock 12500 $0.19 D  
Options, right to buy (p.v. 0.00001) 10/4/2024 4/3/2033 Common Stock 12500 $0.19 D  
Options, right to buy (p.v. 0.00001) 4/4/2025 4/3/2033 Common Stock 12500 $0.19 D  
Restricted Share Units (p.v.0.00001)  (2)1/29/2026 Common Stock 40000 $0 D  
Explanation of Responses:
(1) The award vests as follows: 25% on each of January 29, 2024; 2025; 2026 and 2027, each vesting subject to acceleration upon Issuer's common stock achieving a specified price per share.
(2) Each performance right represents a contingent right to receive one share of Issuer's common stock. The performance rights vest upon Issuer's common stock achieving a specified price per share.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Kalayajian Karen
4896 RUE EDOUARD-BRUNETTE
LAVAL, A8 H7T 0J4

VP, Finance&Admin - Subsidiary
Signatures
/s/ Ingrid Zerbe for Karen Kalayajian4/19/2023
**Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
IntelGenx Technologies (PK) (USOTC:IGXT)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas IntelGenx Technologies (PK).
IntelGenx Technologies (PK) (USOTC:IGXT)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas IntelGenx Technologies (PK).